Medline Inc. Deferred Income Tax Expense (Benefit)
Medline Inc. (MDLN) reported Deferred Income Tax Expense (Benefit) of $101.00 million for the 6-month period ending 2026-06-27, per its 10-Q filed 2026-08-05.
Financial Statements › Cash Flow › Operating Activities
us-gaap:DeferredIncomeTaxExpenseBenefit · last filed 2026-08-05
- Medline Inc. deferred income tax expense (benefit) for the quarter ending 2026-06-27 was $64.00M.
- Medline Inc. deferred income tax expense (benefit) for the quarter ending 2026-03-28 was $37.00M.
- Medline Inc. deferred income tax expense (benefit) for the quarter ending 2025-06-28 was -$3.00M.
- Medline Inc. deferred income tax expense (benefit) for the quarter ending 2025-03-29 was -$4.00M.
- Medline Inc. deferred income tax expense (benefit) for fiscal 2025 was -$20.00M.
- Medline Inc. deferred income tax expense (benefit) for fiscal 2024 was -$24.00M.
- Medline Inc. deferred income tax expense (benefit) for fiscal 2023 was -$23.00M.
| Period end | Deferred Income Tax Expense (Benefit) 3 month | Deferred Income Tax Expense (Benefit) 6 month | Deferred Income Tax Expense (Benefit) 12 month |
|---|---|---|---|
| 2026-06-27 | $64.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-05 | $101.00M 10-Q · filed 2026-08-05 | |
| 2026-03-28 | $37.00M 10-Q · filed 2026-05-06 | ||
| 2025-12-31 | -$20.00M 10-K · filed 2026-02-25 | ||
| 2025-06-28 | -$3.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-05 | -$7.00M 10-Q · filed 2026-08-05 | |
| 2025-03-29 | -$4.00M 10-Q · filed 2026-05-06 | ||
| 2024-12-31 | -$24.00M 10-K · filed 2026-02-25 | ||
| 2023-12-31 | -$23.00M 10-K · filed 2026-02-25 |